Cargando…
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
BACKGROUND: In multiple sclerosis (MS), immune up-regulation is coupled to subnormal immune response to interferon-β (IFN-β) and low serum IFN-β levels. The relationship between the defect in IFN signalling and acute and long-term effects of IFN-β on gene expression in MS is inadequately understood....
Autores principales: | Feng, Xuan, Bao, Riyue, Li, Lei, Deisenhammer, Florian, Arnason, Barry G.W., Reder, Anthony T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945282/ https://www.ncbi.nlm.nih.gov/pubmed/31648992 http://dx.doi.org/10.1016/j.ebiom.2019.09.059 |
Ejemplares similares
-
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis
por: Croze, E, et al.
Publicado: (2013) -
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
por: Cohan, Stanley L., et al.
Publicado: (2021) -
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology
por: Reder, Anthony T., et al.
Publicado: (2013) -
Early stage and long term treatment of multiple sclerosis with interferon-β
por: Applebee, Angela, et al.
Publicado: (2009) -
Vitamin D enhances responses to interferon-β in MS
por: Feng, Xuan, et al.
Publicado: (2019)